Literature DB >> 30393609

Development of biomarkers for real precision medicine.

Masahiro Shibata1, Mohammad Obaidul Hoque1.   

Abstract

Entities:  

Year:  2018        PMID： 30393609      PMCID： PMC6193891          DOI： 10.21037/tlcr.2018.08.07

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  23 in total

1.  First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Authors:  Benjamin J Solomon; Tony Mok; Dong-Wan Kim; Yi-Long Wu; Kazuhiko Nakagawa; Tarek Mekhail; Enriqueta Felip; Federico Cappuzzo; Jolanda Paolini; Tiziana Usari; Shrividya Iyer; Arlene Reisman; Keith D Wilner; Jennifer Tursi; Fiona Blackhall
Journal:  N Engl J Med       Date:  2014-12-04       Impact factor: 91.245

2.  Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer.

Authors:  Gavitt A Woodard; Sue X Wang; Johannes R Kratz; Clara T Zoon-Besselink; Chun-Yuan Chiang; Matthew A Gubens; Thierry M Jahan; Collin M Blakely; Kirk D Jones; Michael J Mann; David M Jablons
Journal:  Clin Lung Cancer       Date:  2017-05-31       Impact factor: 4.785

3.  Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma.

Authors:  Ignacio I Wistuba; Carmen Behrens; Francesca Lombardi; Susanne Wagner; Junya Fujimoto; M Gabriela Raso; Lorenzo Spaggiari; Domenico Galetta; Robyn Riley; Elisha Hughes; Julia Reid; Zaina Sangale; Steven G Swisher; Neda Kalhor; Cesar A Moran; Alexander Gutin; Jerry S Lanchbury; Massimo Barberis; Edward S Kim
Journal:  Clin Cancer Res       Date:  2013-09-18       Impact factor: 12.531

4.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

5.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

6.  Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer.

Authors:  Gerold Bepler; Charles Williams; Michael J Schell; Wei Chen; Zhong Zheng; George Simon; Shirish Gadgeel; Xiuhua Zhao; Fred Schreiber; Julie Brahmer; Alberto Chiappori; Tawee Tanvetyanon; Mary Pinder-Schenck; Jhanelle Gray; Eric Haura; Scott Antonia; Juergen R Fischer
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

7.  Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma.

Authors:  Raphael Bueno; Elisha Hughes; Susanne Wagner; Alexander S Gutin; Jerry S Lanchbury; Yifan Zheng; Michael A Archer; Corinne Gustafson; Joshua T Jones; Kristen Rushton; Jennifer Saam; Edward Kim; Massimo Barberis; Ignacio Wistuba; Richard J Wenstrup; William A Wallace; Anne-Renee Hartman; David J Harrison
Journal:  J Thorac Oncol       Date:  2015-01       Impact factor: 15.609

8.  Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer.

Authors:  Federico Rotolo; Chang-Qi Zhu; Elisabeth Brambilla; Stephen L Graziano; Ken Olaussen; Thierry Le-Chevalier; Jean-Pierre Pignon; Robert Kratzke; Jean-Charles Soria; Frances A Shepherd; Lesley Seymour; Stefan Michiels; Ming-Sound Tsao
Journal:  Transl Lung Cancer Res       Date:  2018-06

Review 9.  Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysis.

Authors:  Yanlong Yang; Yuanliang Xie; Lei Xian
Journal:  J Exp Clin Cancer Res       Date:  2013-03-15

Review 10.  The detection and implication of genome instability in cancer.

Authors:  Larissa Pikor; Kelsie Thu; Emily Vucic; Wan Lam
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.